Daily notes / October 19, 2026
United Therapeutics (UTHR) on October 19, 2026: 13 filings in one day
By OQRO's software, from the records of . Published . 2 min read.
The short answer
On October 19, 2026, 13 filings about United Therapeutics (UTHR) entered OQRO's records: 13 insider sales. That made it one of the busiest listed companies of the day. Each line below links to the filing as it was made with the SEC, the House, the Senate or USAspending.
What was filed about United Therapeutics on October 19, 2026?
13 filings about United Therapeutics carried the date October 19, 2026 in OQRO's records: 13 insider sales. It was one of the busiest companies of the day by number of filings.
Which filings?
- CEO sold ~$1.27M of UTHR shares in the open market (Martine A Rothblatt, Chairperson & CEO), dated Oct 16, 2026: the filing
- CEO sold ~$970K of UTHR shares in the open market (Martine A Rothblatt, Chairperson & CEO), dated Oct 16, 2026: the filing
- CEO sold ~$544K of UTHR shares in the open market (Martine A Rothblatt, Chairperson & CEO), dated Oct 16, 2026: the filing
- CEO sold ~$464K of UTHR shares in the open market (Martine A Rothblatt, Chairperson & CEO), dated Oct 16, 2026: the filing
- CEO sold ~$409K of UTHR shares in the open market (Martine A Rothblatt, Chairperson & CEO), dated Oct 16, 2026: the filing
- CEO sold ~$342K of UTHR shares in the open market (Martine A Rothblatt, Chairperson & CEO), dated Oct 16, 2026: the filing
- CEO sold ~$287K of UTHR shares in the open market (Martine A Rothblatt, Chairperson & CEO), dated Oct 16, 2026: the filing
- CEO sold ~$216K of UTHR shares in the open market (Martine A Rothblatt, Chairperson & CEO), dated Oct 16, 2026: the filing
- CEO sold ~$212K of UTHR shares in the open market (Martine A Rothblatt, Chairperson & CEO), dated Oct 16, 2026: the filing
- CEO sold ~$129K of UTHR shares in the open market (Martine A Rothblatt, Chairperson & CEO), dated Oct 16, 2026: the filing
- CEO sold ~$127K of UTHR shares in the open market (Martine A Rothblatt, Chairperson & CEO), dated Oct 16, 2026: the filing
- CEO sold ~$92K of UTHR shares in the open market (Martine A Rothblatt, Chairperson & CEO), dated Oct 16, 2026: the filing
- CEO sold ~$22K of UTHR shares in the open market (Martine A Rothblatt, Chairperson & CEO), dated Oct 16, 2026: the filing
What this does not tell you
Several filings on one day usually share a cause that the filings do not state: a 13F deadline, a trading window after results, a grant date. The United Therapeutics page shows every filing with its source, the price next to it and a dated summary of the last 12 months. This page lists what was filed on one day, with each record linked to its source. A filing does not say why it was made, and this is not investment advice.
Sources
No language model wrote this page: every figure is one of the day's records, linked to its filing. It describes what was filed, not why, and it is not investment advice. How OQRO treats data
Explore the data
More daily notes
- Chernett Jorey reported an Exagen share purchase on Form 4
- Robert Nelsen reported a City Therapeutics open-market purchase
- Control Empresarial reported a Talos Energy share sale on Form 4
- Harel filed a Schedule 13G reporting a 5.2% stake in Elbit Systems
- JP Sailing Capital filed a Schedule 13G on Nextcure
- Norbel Investments filed a Schedule 13G on Papa John's Pizza